1-(2-BROMOETHOXY)-3-METHYLBENZENE – (6512-13-6)

566169-93-5, 2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol, 6-OH-BTA-1, 2-[4-(methylamino)phenyl]-1, 3-benzothiazol-6-ol, Pittsburgh compound B unlabelled, MFCD17018727, 2-(4'-methylaminophenyl)-6-hydroxybenzothiazole, CHEMBL93124, K6396E6G8G, 2-[4-(Methylamino)phenyl]benzo[d]thiazol-6-ol, UNII-K6396E6G8G, IZV, SCHEMBL912744, EX-A7898B, ZQAQXZBSGZUUNL-UHFFFAOYSA-N, BDBM50129793, AKOS022184240, 4-methylamino-phenyl)-benzothiazol-6-ol, SY274908, 2-(4'-Aminophenyl)-6-hydroxybenzo-thiazole, 2-(4-Methylamino-phenyl)-benzothiazol-6-ol, 2-[4-(Methylamino)phenyl]benzothiazol-6-ol, CS-0092545, Y11631, 2-(4''''-methylaminophenyl)-6-hydroxybenzothiazole, [3H]2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol, Q27282003, 2-[4-(N-monomethyl)aminophenyl]-6-hydroxybenzothiazole, 6-Hydroxy-2-(4''''-N-methylaminophenyl)-1, 3-benzothiazole, N-methyl-2-(4''''-methylaminophenyl)-6-hydroxybenzothiazole, N-methyl-[11C]2-(40-methylaminophenyl)-6-hydroxy benzothiazole